1
/
of
1
My Store
Retatrutide 20mg
Retatrutide 20mg
Regular price
$140.00 USD
Regular price
Sale price
$140.00 USD
Unit price
/
per
Couldn't load pickup availability
Retatrutide is a medication in development, particularly for the treatment of obesity. It acts as a triple-agonist, meaning it targets and activates three different hormone receptors: GLP-1, GIP, and glucagon receptors.
Lyophilized powder
Purity - 99.9%
Volume - 20mg/vial
Mechanism of Action & Potential Benefits:
-
By activating these receptors, retatrutide can influence several metabolic processes, including:
- Appetite regulation: Increased satiety and reduced hunger drive.
- Increased energy expenditure: Potentially due to glucagon receptor activation.
- Improved glucose homeostasis: Leading to better blood sugar control.
- Fat metabolism: Potential benefits in fat metabolism, enhancing the effects of GLP-1 and GIP.
- Cardiometabolic markers: Potential improvements in cardiovascular risk factors and markers of insulin resistance.
- Metabolic dysfunction-associated steatotic liver disease (MASLD): Studies suggest it can significantly reduce liver fat.
Clinical Trial Results (Phase 2):
- In a Phase 2 trial of adults with obesity or overweight, retatrutide demonstrated substantial weight loss.
- At 48 weeks, the highest dose (12 mg) resulted in a mean weight reduction of 24.2%, or approximately 58 pounds.
- Significant weight reduction of 5% or more was achieved in a high percentage of participants, especially at higher doses.
Share
